Is the Affinity Column-Mediated Immunoassay Method Suitable as an Alternative to the Microparticle Enzyme Immunoassay Method as a Blood Tacrolimus Assay?

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3673-3678

  Ju, M K ^a   Chang, H K ^a   Kim, H J ^a   Huh, K H ^a   Ahn, H J ^a   Kim, M S ^a   Kim, S I ^a   Kim, Y S ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; AFFINITY COLUMN MEDIATED IMMUNOASSAY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMICAL ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CORRELATION ANALYSIS; DRUG MONITORING; FEMALE; GRAFT RECIPIENT; HEMATOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KIDNEY FUNCTION; KIDNEY GRAFT; LIVER FUNCTION; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

BILIRUBIN; CHROMATOGRAPHY, AFFINITY; CREATININE; HEMATOCRIT; HUMANS; IMMUNOASSAY; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TACROLIMUS;

EID: 57549088671     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.04.019     Document Type: Article

References (14)

1. Ollerich M., Armstrong V.W., Schutz E., et al. Therapeutic drug monitoring of cyclosporin and tacrolimus. Clin Biochem 31 (1998) 309
2. Fahr A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 24 (1993) 472
3. Cogil J.L., Taylor P.J., Westley I.S., et al. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 44 (1998) 1942
4. Nagase K., Iwasaki K., Nozaki K., et al. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol 46 (1994) 113
5. Nigel W.B., Christopher E.G., Jemimah E.A., et al. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. Clin Chem 51 (2005) 586
6. Tacrolimus II: IMx System. Ref 3C10, 34-3782/R7. Abbott Park, Ill Abbott Laboratories
7. O'Connor M: Dimension TACR Technical Training, 06/06. Newark, Del: Dade Behring
8. Griffey M.A., Hock K.G., Kilgore D.C., et al. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer. Clin Chim Acta 384 (2007) 48
9. Kuzuya T., Ogura Y., Motegi Y., Moriyama N., et al. Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay. Ther Drug Monit 24 (2002) 507
10. Homma M., Tomita T., Yuzawa K., et al. False positive blood tacrolimus concentration in microparticle enzyme immunoassay. Biol Pharm Bull 25 (2002) 1119
11. Chow F.S., Piekoszewski W., and Jusko W.J. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab Dispos 25 (1997) 610
12. Taylor P.J., and Morris R.G. Tacrolimus measurement by microparticle enzyme immunoassay II. Ther Drug Monit 25 (2003) 259
13. Cogill J.L., Taylor P.J., Westley I.S., et al. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 44 (1998) 1942
14. Armstrong V.W., Schuetz E., Zhang Q., et al. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites:comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II). Clin Chem 44 (1998) 2516